- The PCORI Strategic Plan
- Our Programs
- Our Vision & Mission
- Financial Statements and Reports
- The PCORI Strategic Plan
- Board of Governors
- Methodology Committee
- Authorizing Law
- Evaluating Our Work
- PCORI's Advisory Panels
- Procurement Opportunities
Past Opportunities to Provide Input
- Patient-Centered Economic Outcomes Landscape (2023-2024)
- Systematic Review of Audio Care for the Management of Mental Health and Chronic Conditions (2023) -- Draft Key Questions
- Proposed New Methodology Standards for Usual Care as a Comparator (2023)
- Stakeholder Views on Components of 'Patient-Centered Value' in Health and Health Care (2023)
- PCORI's Proposed Research Agenda (2021-2022)
- Proposed National Priorities for Health (2021)
- Proposed Principles for the Consideration of the Full Range of Outcomes Data in PCORI-Funded Research (2020)
- Proposed New PCORI Methodology Standards (2018)
- Data Access and Data Sharing Policy: Public Comment (2017)
- Proposed New PCORI Methodology Standards (2017)
Comment on the Proposed New and Revised PCORI Methodology Standards (2016)
- 1. Standards for Formulating Research Questions
- 10: Standards for Studies of Diagnostic Tests
- 12. Standards on Research Designs Using Clusters
- 13: General Comments on the Proposed Revisions to the PCORI Methodology Standards
- 2: Standards Associated with Patient-Centeredness
- 3: Standards for Data Integrity and Rigorous Analysis
- 4: Standards for Preventing and Handling Missing Data
- 5: Standards for Heterogeneity of Treatment Effects
- 6: Standards for Data Registries
- 7: Standards for Data Networks as Research-Facilitating Structures
- 8. Standards for Causal Inference Methods
- 9. Standards for Adaptive Trial Designs
- Peer-Review Process Comments (2014)
- Draft Methodology Report Public Comment Period (2012)
- Past Opportunities to Provide Input
WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) announced today that Harold I. Feldman, M.D., MSCE, will join PCORI as its first Deputy Executive Director for Patient-Centered Research Programs effective July 1, 2022. In this key role, Feldman will work closely with PCORI’s leaders and staff to realize the fulfillment of the institution’s mission to improve the quality and relevance of evidence available to help patients, caregivers, clinicians, employers, insurers and policy makers make better-informed health decisions.
“It is my great pleasure to welcome a leader of Dr. Feldman’s caliber to PCORI,” said PCORI Executive Director Nakela L. Cook, M.D., MPH. “He brings us a wealth of experience and expertise critical to leading PCORI at a pivotal and exciting time in our evolution following our reauthorization in 2019. We look forward to benefiting from Dr. Feldman’s experience and working closely with him.”
“I am very excited and honored to be joining PCORI, whose mission and culture are fully aligned with my values and experience,” Feldman said. “I look forward to being part of an organization with such impact on population health and in which I can continue pursuing my passion to empower people to improve health and reduce health inequities.”
As the nation’s largest public funder of comparative clinical effectiveness research (CER), PCORI’s programmatic unit manages a $3.3 billion portfolio of CER studies and research-related projects. Throughout its work, PCORI emphasizes the engagement of patients and other health care decision makers as critical partners in guiding and shaping clinical research. PCORI also pursues initiatives to ensure that useful results of patient-centered CER are implemented in clinical practice.
To support these essential activities, Feldman will oversee and provide strategic coherence across a diverse array of programmatic activities at PCORI. These include the funding of research studies and research-related projects, such as infrastructure development and evidence synthesis; engagement of the healthcare community in PCORI’s work and management of stakeholder partnerships; and initiatives to advance dissemination and implementation of research findings.
In addition, through his decades of experience in creating opportunities for others as a department chair, leader of national research programs and journal editor-in-chief among other roles, Feldman will work to engage, motivate and develop a diverse PCORI staff. He also will contribute to advancing PCORI’s ongoing efforts to promote diversity, equity and inclusion in all facets of its work.
Feldman’s experience, expertise and background are ideally suited to the responsibilities he will fulfill at PCORI. Feldman comes to PCORI from the University of Pennsylvania Perelman School of Medicine, where he holds several key leadership roles. These include director and senior scholar at the Center for Clinical Epidemiology and Biostatistics, where he directs and leads researchers in investigating a wide range of population health science questions related to clinical medicine, and director emeritus of the Robert Wood Johnson Foundation Clinical Scholars Program. Among other positions, he is a George S. Pepper Professor of Public Health and Preventative Medicine and senior fellow at the Center for Public Health Initiatives.
As a nephrologist and epidemiologist, Feldman has extensive research and clinical expertise. As a physician, he understands the health care choices that patients, caregivers, clinicians and others in the health care community face and the importance of an organization like PCORI to shed light on these dilemmas. He is the national study chair of the Chronic Renal Insufficiency Cohort Study, one of the National Institutes of Health’s largest and longest ongoing studies looking at the causes, frequency and consequences of chronic kidney disease in the United States. Under his leadership, the study has realized many findings that can lessen kidney diseases’ morbidity and mortality rates. Most recent among these has been work addressing and identifying solutions for the problem of race-based approaches to diagnosing kidney disease that are widely seen as perpetuating health disparities in nephrology.
Feldman was the president of the American College of Epidemiology between 2016 and 2017. He has published more than 300 peer-reviewed papers and is the editor-in-chief of the National Kidney Foundation’s American Journal of Kidney Diseases.
Feldman earned his bachelor of arts and doctor of medicine at Boston University before completing his residency in internal medicine at the University of California, Los Angeles. He then completed fellowships in clinical epidemiology, general internal medicine and nephrology as well as graduate training in clinical epidemiology at the University of Pennsylvania.
The Patient-Centered Outcomes Research Institute (PCORI) is the nation’s leading funder of patient-centered comparative clinical effectiveness research (CER). By comparing two or more health or healthcare approaches, CER generates evidence that helps people make better-informed decisions and improves healthcare delivery and outcomes. PCORI takes a holistic approach to its work, ensuring that patients and other health decision makers are engaged as partners throughout the research process, supporting dissemination and implementation of results in practice and strengthening clinical research infrastructure to advance patient-centered CER. PCORI is an independent, non-profit organization authorized by Congress.